Print this page    •   Back to Web version of article

Table of Contents

February 1996

CLINICAL CARE

Does PCP Prophylaxis Improve Survival in Patients with HIV Infection?

New data suggest new approaches to clinical management
NEIL M.H. GRAHAM, M.B.B.S., M.D., M.P.H.


NEWSLINE

Newsline ... Newsline ... Newsline ...

Two studies establish efficacy of ritonavir: New protease inhibitor has prompt and potent antiretroviral activity ... Ritonavir prevents disease progression and prolongs life: First evidence of the clinical benefit of protease inhibition ... Potent, sustained antiviral activity of ZDV and 3TC combined with indinavir: Most powerful drug combination yet studied


OPTIMAL MEDICAL MANAGEMENT

Coccidioidomycosis and HIV Disease

Clinical manifestations, and effective treatment, of an endemic infection
JON E. LUTZ, M.D., DAVID A. STEVENS, M.D., GEORGE A. SAROSI, M.D.



This article was provided by San Francisco General Hospital. It is a part of the publication HIV Newsline. You can find this article online by typing this address into your Web browser:
http://www.thebody.com/content/art12588.html

General Disclaimer: TheBody.com is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through TheBody.com should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.